Illumina Inc (NASDAQ:ILMN) — Market Cap & Net Worth
Market Cap & Net Worth: Illumina Inc (ILMN)
Illumina Inc (NASDAQ:ILMN) has a market capitalization of $18.34 Billion ($18.34 Billion) as of May 2, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #1373 globally and #542 in its home market, demonstrating a 8.24% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Illumina Inc's stock price $135.78 by its total outstanding shares 152800000 (152.80 Million). Analyse how efficiently does Illumina Inc generate cash to see how efficiently the company converts income to cash.
Illumina Inc Market Cap History: 2015 to 2026
Illumina Inc's market capitalization history from 2015 to 2026. Data shows change from $28.53 Billion to $20.75 Billion (-0.52% CAGR).
Index Memberships
Illumina Inc is a constituent of 6 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
ARCA Biotechnology
BTK
|
$910.33 Billion | 2.01% | #14 of 30 |
|
Dow Jones Biotechnology
DJUSBT
|
$1.09 Trillion | 1.68% | #10 of 39 |
|
NASDAQ Health Care
IXHC
|
$2.41 Trillion | 0.76% | #22 of 976 |
|
NASDAQ Composite
IXIC
|
$38.77 Trillion | 0.05% | #163 of 3165 |
|
S&P Midcap 400
MID
|
$3.36 Trillion | 0.45% | #26 of 401 |
|
NASDAQ Biotechnology
NBI
|
$1.67 Trillion | 1.10% | #15 of 263 |
Weight: Illumina Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Illumina Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Illumina Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
4.62x
Illumina Inc's market cap is 4.62 times its annual revenue
Latest Price to Earnings (P/E) Ratio
23.58x
Illumina Inc's market cap is 23.58 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $19.03 Billion | $2.40 Billion | $462.65 Million | 7.94x | 41.14x |
| 2017 | $32.48 Billion | $2.75 Billion | $726.00 Million | 11.80x | 44.73x |
| 2018 | $44.58 Billion | $3.33 Billion | $826.00 Million | 13.38x | 53.97x |
| 2019 | $49.31 Billion | $3.54 Billion | $1.00 Billion | 13.92x | 49.21x |
| 2020 | $55.00 Billion | $3.24 Billion | $656.00 Million | 16.98x | 83.84x |
| 2021 | $56.55 Billion | $4.53 Billion | $762.00 Million | 12.49x | 74.21x |
| 2022 | $30.05 Billion | $4.58 Billion | -$4.40 Billion | 6.56x | N/A |
| 2023 | $20.70 Billion | $4.50 Billion | -$1.16 Billion | 4.60x | N/A |
| 2024 | $20.42 Billion | $4.37 Billion | -$1.22 Billion | 4.67x | N/A |
| 2025 | $20.04 Billion | $4.34 Billion | $850.00 Million | 4.62x | 23.58x |
Competitor Companies of ILMN by Market Capitalization
Companies near Illumina Inc in the global market cap rankings as of May 2, 2026.
Key companies related to Illumina Inc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #126 globally with a market cap of $176.29 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #189 globally with a market cap of $123.72 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #578 globally with a market cap of $45.31 Billion USD.
- LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #643 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #126 | Thermo Fisher Scientific Inc | NYSE:TMO | $176.29 Billion | $469.21 |
| #189 | Danaher Corporation | NYSE:DHR | $123.72 Billion | $175.15 |
| #578 | IDEXX Laboratories Inc | NASDAQ:IDXX | $45.31 Billion | $567.46 |
| #643 | LONZA GROUP UNSP.ADR 1/10 | F:LO3A | $41.04 Billion | €54.50 |
Illumina Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Illumina Inc's market cap moved from $28.53 Billion to $ 20.75 Billion, with a yearly change of -0.52%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $20.75 Billion | +3.52% |
| 2025 | $20.04 Billion | -1.85% |
| 2024 | $20.42 Billion | -1.34% |
| 2023 | $20.70 Billion | -31.14% |
| 2022 | $30.05 Billion | -46.85% |
| 2021 | $56.55 Billion | +2.82% |
| 2020 | $55.00 Billion | +11.53% |
| 2019 | $49.31 Billion | +10.61% |
| 2018 | $44.58 Billion | +37.27% |
| 2017 | $32.48 Billion | +70.64% |
| 2016 | $19.03 Billion | -33.30% |
| 2015 | $28.53 Billion | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Illumina Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $18.34 Billion USD |
| MoneyControl | $18.34 Billion USD |
| MarketWatch | $18.34 Billion USD |
| marketcap.company | $18.34 Billion USD |
| Reuters | $18.34 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Illumina Inc
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and … Read more